George Church

AbVitro LLC provided an antibody discovery platform. The company was founded by George W. Church, Uri Laserson, Mirza Cifric and Francois Vigneault in 2010 and headquartered in Seattle, WA.

National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC.

Inari Agriculture, Inc. engages biotechnology research and development. It specializes in plant breeding technology. The company was founded by David Berry, Ignacio Martinez, George Church, and Steve Jacobsen in 2016 and is headquartered in Cambridge, MA.

enEvolv, Inc. provides genome engineering services. It engineers and licenses microorganisms to produce chemicals enzymes and small molecules for a variety of industries including specialty chemicals, food, energy, personal care, and pharmaceuticals. The company was founded by George McDonald Church, Marco M. Farsheed, Farren J. Isaacs, and Jay Harris Konieczka in 2011 and is headquartered in Boston, MA.

Veritas Genetics, Inc. provides breast and ovarian cancer genetic testing services. It operates business through Veritas whole genome sequencing and targeted genetic testing products. The company was founded by Mirza Cifric, Preston Estep III, Joseph Thakuria, Jonathan Zhao and George MacDonald Church in 2014 and is headquartered in Danvers, MA.

ReadCoor, Inc. operates sequencing platform. The firm develops Fluorescence In-situ Sequencing technology, which enables integration of high throughput sequencing, morphometric analysis, cellular location and three dimensional spatial imaging. The company was founded by Richard Terry, Marcell M. Shawn, Evan R. Daugharthy, and George M. Church in 2014 and is headquartered in Cambridge, MA.

eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.

Codon Devices, Inc. produces pharmaceuticals and biorefineries for the production of industrial chemicals and bio-energy. The firm designs and constructs biological components such as enzymes, biopharmaceuticals, and cell lines for improved function. Its customers include the biotechnology, pharmaceutical, and agriculture sectors. The company was founded by Noubar B. Afeyan, George Church, Drew Endy, Joseph M. Jacobson and Jay Keasling in 2004 and is headquartered in Cambridge, MA.

GRO Biosciences, Inc. develops genomically recoded organisms to express therapeutic proteins. The company was founded by George McDonald Church, Andrew D. Ellington, Daniel J. Mandell, Christopher J. Gregg, P. Benjamin Stranges, Marc J. Lajoie, and Ross Thyer in 2016 and is headquartered in Cambridge, MA.

Cambrian Genomics, Inc. assembles, sequences and laser-prints strands of DNA. The company is headquartered in San Francisco, CA.

Nebula Genomics, Inc. operates a platform that will use block chain technology to decentralize genome sequencing. The company was founded by Dennis Grishin, George McDonald Church and Kamal Obbad in 2016 and is headquartered in Boston, MA.

Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The company is based in Washington.

Synvitrobio, Inc. operates as a molecule and drug discovery firm. The company was founded by Zachary Sun, George Church, Richard Murray in 2015 and is headquartered in San Francisco, CA.

Genia Technologies, Inc. develops DNA sequencing platforms. Its nanopore-based platform allows for single molecule, electrical real-time analysis without the need for complicated optics, labels, and amplification, or fluidics. The firm's sequencing platform enables the use of molecular diagnostics in everyday clinical care. The company was founded by Roger Chen, Stefan Roever, Pratima Rao, and Randy Davis in March 2009 and is headquartered in Santa Clara, California

Petri is a venture capital firm founded in 2019 by Andy Beck, Daphne Koller, Emily Leproust, Chris Voigt, Reshma Shetty, Alec Nielsen, Bernhard van Lengerich,Stan Lapidus, Pam Silver, JP Mangeolle and George Church. The firm is headquartered in Boston, MA.

Fitbiomics, Inc. operates as a microbiome biotechnology company. The firm utilizes next-generation sequencing to understand what makes elite athletes unique. The company was founded by Jonathan Scheiman, George Church, Alex Evans, Aleksandar Kostic, Carolina Barsa, Vasco Bridges and Treasure Neal and is headquartered in New York, NY.

64-X, Inc. engages in the design and development of cells with enhanced properties for advanced bio-manufacturing and therapeutics applications. The firm also provides research and development services. The company was founded by George Church, Alexis Rovner, Pam Silver, and Jeff Way in 2017 and is headquartered in San Francisco, CA.

Colossal Biosciences, Inc. is a company that uses CRISPR technology to try to bring back extinct species. The company is based in Austin, TX. The company was founded by George McDonald Church and Ben Lamm, with Ben Lamm serving as CEO since its incorporation.

Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York.

GC Therapeutics, Inc. is a company based in Cambridge, MA. GC Therapeutics uses synthetic biology to program stem cells into any cell type with efficiency, speed, and scalability. The company has validated cells for many applications and have developed supercells™ by tailoring cells for specific diseases. The company's goal is to bring this breakthrough approach to patients. The company was founded in 2019 by Parastoo Khoshakhlagh, Alex Ng, Cory Smith, and George McDonald Church, with Parastoo Khoshakhlagh as the CEO since 2019.

Kern Systems, Inc. operates as an application to store data into deoxyribonucleic acid. Its applications allow data to restore, trace and track, and with big data storage capacity. The company was founded by Henry H. Lee and George M. Church and is headquartered in Brookline, MA.

Volta Labs, Inc. engages in building computational and automation tools to engineering biology. The company is headquartered in Cambridge, MA.

Intelligent Bio-Systems is developing a next generation DNA sequencing system that can simultaneously increase the speed and reduce the cost of producing sequence data by a factor of 100 to 1,000. It uses a proprietary chemistry, high-density chip and fluorescent instrument system to accurately decode the sequence of DNA fragments. The technology has the potential to dramatically change the way research is performed and healthcare is delivered.

Joule Unlimited Technologies, Inc. produces renewable fuels and chemicals. It offers a technology platform for liquid fuel from the Sun. The company was founded by Noubar B. Afeyan in 2007 and is headquartered in Bedford, MA.

Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.

Good Start Genetics, Inc. operates as a molecular diagnostics firm. It offers pre-pregnancy diagnostic test services to screen a panel of genetic disorders. The firm also provides clinical laboratory and genetic counseling support services. The company was founded by Eric Boutin, Paris Wallace, and Gregory J. Porreca in December 2007 and is headquartered in Cambridge, MA.

Lynx Therapeutics, Inc. was a developer of genetic analysis products for the pharmaceutical, biotechnology and agriculture industries. It's MPSSTM instruments analyze millions of DNA molecules in parallel enabling genome structure characterization at an unprecedented level of resolution. MPSSTM provides comprehensive and quantitative digital information important to modern systems biology research in the pharmaceutical, biotechnology and agricultural industries. The company was headquartered in Hayward, CA.

Agencourt Bioscience Corp. provides genomic services and nucleic acid purification products. Its services enable biotechnology, pharmaceutical, government, and academic research laboratories to develop new drugs. The company was founded in July, 2000 by R. Brian McKernan, Kevin J. McKernan, and Brendan L. McKernan and is headquartered in Beverly, MA

Boutique Venture Partners LLC (Boutique Venture Partners) is a venture capital firm founded in 2020 by S. Thaddeus Connelly and Rami El Assal. The firm is headquartered in Palo Alto, California.

Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then.

JURA Bio, Inc. is an American company founded in 2017 that has developed an end-to-end generative machine learning and synthetic biology platform for the discovery and development of genetic medicines. The private company is based in an undisclosed location. The company's focus is on developing drugs built around the tcr-epitope-hla synapse, and they are developing a map from any antigen-hla pair to any t cell receptor. This map would broadly advance the development of therapeutics for oncology and autoimmune disease.